Turnstone Biologics Corp. (TSBX) Tops Q1 EPS by 17c
Tweet
Share
E-mailGet Alerts TSBX Hot Sheet
Join SI Premium – FREE
Turnstone Biologics Corp. (NASDAQ: TSBX) reported Q1 EPS of ($0.51), $0.17 better than the analyst estimate of ($0.68).
For earnings history and earnings-related data on Turnstone Biologics Corp. (TSBX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Upgrades Portland General Electric Company (POR) to Overweight
- Royal Caribbean (RCL) call put ratio 1 call to 1.8 puts amid price movement
- Winnebago Industries (WGO) September 32.50 calls active
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
